{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T09:22:29Z","timestamp":1762507349090,"version":"3.37.3"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2018,3,16]],"date-time":"2018-03-16T00:00:00Z","timestamp":1521158400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Mirsky Research Fund of our medical center"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Support Care Cancer"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1007\/s00520-018-4143-z","type":"journal-article","created":{"date-parts":[[2018,3,16]],"date-time":"2018-03-16T08:35:32Z","timestamp":1521189332000},"page":"3013-3020","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Bone loss and hematological malignancies in adults: a pilot study"],"prefix":"10.1007","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8349-0794","authenticated-orcid":false,"given":"Rosa","family":"Ruchlemer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michal","family":"Amit-Kohn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ariella","family":"Tvito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irena","family":"Sindelovsky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ari","family":"Zimran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Raveh-Brawer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,3,16]]},"reference":[{"key":"4143_CR1","unstructured":"Foundation IO: Osteoporosis and musculoskeletal disorders; Epidemiology"},{"key":"4143_CR2","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.1002\/cncr.22546","volume":"109","author":"A Sala","year":"2007","unstructured":"Sala A, Barr RD (2007) Osteopenia and cancer in children and adolescents: the fragility of success. Cancer 109:1420\u20131431","journal-title":"Cancer"},{"key":"4143_CR3","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1002\/pbc.23300","volume":"58","author":"LE Cohen","year":"2012","unstructured":"Cohen LE, Gordon JH, Popovsky EY, Sainath NN, Feldman HA, Kieran MW, Gordon CM (2012) Bone density in post-pubertal adolescent survivors of childhood brain tumors. Pediatr Blood Cancer 58:959\u2013963","journal-title":"Pediatr Blood Cancer"},{"key":"4143_CR4","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1093\/annonc\/mdt560","volume":"25","author":"J Paccou","year":"2014","unstructured":"Paccou J, Merlusca L, Henry-Desailly I, Parcelier A, Gruson B, Royer B, Charbonnier A, Ursu D, Desailloud R, Garidi R, Kamel S, Sevestre H, Marolleau JP, Fardellone P, Damaj G (2014) Alterations in bone mineral density and bone turnover markers in newly diagnosed adults with lymphoma receiving chemotherapy: a 1-year prospective pilot study. Ann Oncol 25:481\u2013486","journal-title":"Ann Oncol"},{"key":"4143_CR5","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.1038\/sj.leu.2402264","volume":"15","author":"G Massenkeil","year":"2001","unstructured":"Massenkeil G, Fiene C, Rosen O, Michael R, Reisinger W, Arnold R (2001) Loss of bone mass and vitamin D deficiency after hematopoietic stem cell transplantation: standard prophylactic measures fail to prevent osteoporosis. Leukemia 15:1701\u20131705","journal-title":"Leukemia"},{"key":"4143_CR6","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1111\/bjh.12581","volume":"163","author":"S Farmer","year":"2013","unstructured":"Farmer S, Horvath-Puho E, Vestergaard H et al (2013) Chronic myeloproliferative neoplasms and risk of osteoporotic fractures; a nationwide population-based cohort study. Br J Haematol 163:603\u2013610","journal-title":"Br J Haematol"},{"key":"4143_CR7","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1182\/blood-2011-04-348151","volume":"119","author":"BJ Frisch","year":"2012","unstructured":"Frisch BJ, Ashton JM, Xing L, Becker MW, Jordan CT, Calvi LM (2012) Functional inhibition of osteoblastic cells in an in vivo mouse model of myeloid leukemia. Blood 119:540\u2013550","journal-title":"Blood"},{"key":"4143_CR8","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1038\/bonekey.2014.67","volume":"3","author":"BJ Frisch","year":"2014","unstructured":"Frisch BJ, Calvi LM (2014) Osteoblasts as leukemia-initiating cells. Bonekey Rep 3:572","journal-title":"Bonekey Rep"},{"key":"4143_CR9","first-page":"3441","volume":"81","author":"E Canalis","year":"1996","unstructured":"Canalis E (1996) Clinical review 83: mechanisms of glucocorticoid action in bone: implications to glucocorticoid-induced osteoporosis. J Clin Endocrinol Metab 81:3441\u20133447","journal-title":"J Clin Endocrinol Metab"},{"key":"4143_CR10","doi-asserted-by":"publisher","first-page":"e000014","DOI":"10.1136\/rmdopen-2014-000014","volume":"1","author":"K Briot","year":"2015","unstructured":"Briot K, Roux C (2015) Glucocorticoid-induced osteoporosis. RMD Open 1:e000014","journal-title":"RMD Open"},{"key":"4143_CR11","first-page":"97","volume":"5","author":"ML Svendsen","year":"2013","unstructured":"Svendsen ML, Gammelager H, Svaerke C et al (2013) Hospital visits among women with skeletal-related events secondary to breast cancer and bone metastases: a nationwide population-based cohort study in Denmark. Clin Epidemiol 5:97\u2013103","journal-title":"Clin Epidemiol"},{"key":"4143_CR12","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.2106\/JBJS.J.00160","volume":"93","author":"JJ Schreiber","year":"2011","unstructured":"Schreiber JJ, Anderson PA, Rosas HG, Buchholz AL, Au AG (2011) Hounsfield units for assessing bone mineral density and strength: a tool for osteoporosis management. J Bone Joint Surg Am 93:1057\u20131063","journal-title":"J Bone Joint Surg Am"},{"issue":"8","key":"4143_CR13","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1016\/j.amjmed.2003.12.019","volume":"116","author":"SH Kim","year":"2004","unstructured":"Kim SH, Lim SK, Hahn JS (2004) Effect of pamidronate on new vertebral fractures and bone mineral density in patients with malignant lymphoma receiving chemotherapy. Am J Med 116(8):524\u2013528","journal-title":"Am J Med"},{"key":"4143_CR14","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.clml.2012.11.002","volume":"13","author":"JR Westin","year":"2013","unstructured":"Westin JR, Thompson MA, Cataldo VD, Fayad LE, Fowler N, Fanale MA, Neelapu S, Samaniego F, Romaguera J, Shah J, McLaughlin P, Pro B, Kwak LW, Sanjorjo P, Murphy WA, Jimenez C, Toth B, Dong W, Hagemeister FB (2013) Zoledronic acid for prevention of bone loss in patients receiving primary therapy for lymphomas: a prospective, randomized controlled phase III trial. Clin Lymphoma Myeloma Leuk 13:99\u2013105","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"4143_CR15","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.bone.2013.11.025","volume":"60","author":"M Shinohara","year":"2013","unstructured":"Shinohara M, Chang BY, Buggy JJ et al (2013) The orally available Btk inhibitor ibrutinib (PCI-32765) protects against osteoclast-mediated bone loss. Bone 60:8\u201315","journal-title":"Bone"}],"container-title":["Supportive Care in Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00520-018-4143-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-018-4143-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-018-4143-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,3,15]],"date-time":"2019-03-15T20:27:19Z","timestamp":1552681639000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00520-018-4143-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3,16]]},"references-count":15,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2018,9]]}},"alternative-id":["4143"],"URL":"https:\/\/doi.org\/10.1007\/s00520-018-4143-z","relation":{},"ISSN":["0941-4355","1433-7339"],"issn-type":[{"type":"print","value":"0941-4355"},{"type":"electronic","value":"1433-7339"}],"subject":[],"published":{"date-parts":[[2018,3,16]]},"assertion":[{"value":"27 September 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 March 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 March 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no conflicts of interest.The authors have full control of all primary data and agree that the journal may review our data if requested.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}